Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
Brain metastases are a major reason for lung cancer mortality. Here, the authors modify lonidamine to target mitochondria, and show its therapeutic efficacy in inhibiting lung cancer brain metastasis by inducing autophagic cell death in cancer cells.
Enregistré dans:
Auteurs principaux: | Gang Cheng, Qi Zhang, Jing Pan, Yongik Lee, Olivier Ouari, Micael Hardy, Monika Zielonka, Charles R. Myers, Jacek Zielonka, Katherine Weh, Andrew C. Chang, Guoan Chen, Laura Kresty, Balaraman Kalyanaraman, Ming You |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2a91f216e7964b0b95ec04c9938932cc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
par: Kavindra Nath, et autres
Publié: (2018) -
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
par: Xun Shangguan, et autres
Publié: (2021) -
Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance
par: Enping Chen, et autres
Publié: (2021) -
c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis
par: Jia Zhang, et autres
Publié: (2017) -
The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis
par: Pei-Hua Peng, et autres
Publié: (2021)